MEGAN KAPLAN: Open Payments
NPI 1457904401 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 30 payments from 11 companies in 2025. Trend: 2023 $537 · 2024 $645 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| BrioHealth Solutions, Inc. | 1 | $150 |
| ABIOMED | 10 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $134 |
| Biosense Webster, Inc. | 5 | $107 |
| PFIZER INC. | 3 | $63 |
| United Therapeutics Corporation | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
| Boston Scientific Corporation | 1 | $18 |
Products named: BRIOVAD, CARTO 3, Tyvaso, Kerendia, VYNDAQEL, JASCAYD, ELIQUIS, WINREVAIR.
Industry payments across TX — which companies pay providers there.
